Form 4: CHEMED CEO Sells 2,000 Shares Under 10b5-1 Plan

CHEMED Corp's President and CEO, Kevin J. McNamara, sold 2,000 shares of company capital stock at a weighted average price of $437.55.

Summary

• Kevin J. McNamara, President and CEO, and a Director of CHEMED Corp (CHE), reported a sale of company capital stock.
• The transaction involved the disposition of 2,000 shares of Capital Stock on November 24, 2025.
• The shares were sold at a weighted average price of $437.55 per share, with individual transaction prices ranging from $436.13 to $438.53.
• Following this transaction, McNamara beneficially owns 94,197 shares of CHEMED Corp Capital Stock directly.
• The sale was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.

Sentiment

Score: 5

Explanation: Routine insider sale executed under a pre-arranged 10b5-1 trading plan, which typically indicates a planned diversification or liquidity event rather than a reaction to new material non-public information. The volume is not exceptionally large relative to total holdings.

Stakeholder Impact

• Shareholders: A routine insider sale under a 10b5-1 plan is generally not considered a significant indicator of management's confidence in the company's immediate future, as it is pre-scheduled.

Key Dates

Keywords

CHEMED, CHE, Form 4, Insider Trading, Stock Sale, Kevin J. McNamara, CEO, Director, 10b5-1 Plan